Intensive Care Admissions and Associated Severity of Influenza B Versus A During Influenza B Vaccine-mismatched Seasons.


Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
30 08 2019
Historique:
received: 08 10 2018
accepted: 17 01 2019
pubmed: 5 2 2019
medline: 2 9 2020
entrez: 5 2 2019
Statut: ppublish

Résumé

Patients admitted to hospital with influenza B and A in Jerusalem, Israel, during the 2015-2016 and 2017-2018 influenza seasons demonstrated similar rates of intensive care unit (ICU) admission and associated disease severity. Most (63%) influenza B ICU patients received influenza B-mismatched trivalent vaccine. These findings call into question the equivalence of trivalent and quadrivalent vaccines in preventing severe influenza B.

Identifiants

pubmed: 30715225
pii: 5305596
doi: 10.1093/cid/ciz053
doi:

Substances chimiques

Influenza Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1049-1052

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Auteurs

Maya Korem (M)

Clinical Virology Unit, Department of Clinical Microbiology and Infectious Diseases.

Efrat Orenbuch-Harroch (E)

Clinical Virology Unit, Department of Clinical Microbiology and Infectious Diseases.
Intensive Care Unit, Hadassah Hebrew University Medical Center.

Eli Ben-Chetrit (E)

Infectious Diseases Unit, Shaare Zedek Medical Center.

Sarah Israel (S)

Department of Internal Medicine, Hadassah Mount-Scopus Hebrew University Medical Center.

Matan J Cohen (MJ)

Clalit Health Services, Shaare Zedek Medical Center, Jerusalem.

Sigal Sviri (S)

Intensive Care Unit, Hadassah Hebrew University Medical Center.

Phillip D Levin (PD)

General Intensive Care Unit, Shaare Zedek Medical Center, Jerusalem.

Michal Mandelboim (M)

Central Virology Laboratory, Ministry of Health, Chaim Sheba Medical Center, Ramat-Gan.
Department of Epidemiology and Preventive Medicine, School of Public Health, Sackler Faculty of Medicine, Tel-Aviv University.

Dana G Wolf (DG)

Clinical Virology Unit, Department of Clinical Microbiology and Infectious Diseases.
The Lautenberg Center, the Hebrew University Faculty of Medicine, Jerusalem, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH